Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “OXIDATION-REDUCTION”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 775 records · Page 43Linked to original sources
PubMed1978

Comparative metabolism of lorazepam in man and four animal species.

The metabolic disposition of lorazepam (Wy-4036) in man, dog, cat, rat and miniature swine is compared. Except in the cat, absorption of lorazepam is rapid in these species. Absorption in humans is nearly complete. Lorazepam glucuronide is the major metabolite in all species except the rat in which a dihydrodiol derivative is the main product of lorazepam biotransformation. Lorazepam glucuronide, which has no demonstrable CNS activity, is also present in the plasma of all species investigated. The concentrations of lorazepam in rat brain correlate well with those in plasma but are about three times higher. The urinary route of excretion predominates in man, dog and miniature swine while in the rat the bulk of the drug-related material is eliminated with the feces as a consequence of biliary excretion.

Absorption↗
PubMedDate not supplied

pH and Eh relationships in the body.

This report concerns application of the graphical method for representing pH and Eh relationships in macromolecular systems (see previous paper) to in vivo studies. The author presents reasons for concluding that controlled measurements of urine are satisfactory indicators of changes in pH and Eh in the body whereas blood studies remain relatively constant. The original concept had to be modified because of two little known "reversing phenomena". One is well known to physicians as the "acid rebound" because of the acid reaction of urine when an excess of a base is administered. This is a paradox because it would be expected to be more alkaline. The second phenomenon occurs following hyperoxidation, such as in narcotic addiction, and results in reduction. Both hyperalkalinity and hyperoxidation result in an acid reaction. The author concludes that they are phases of a single phenomenon. It is the basis for "Chapman's law": Unfavorable effects on the body cause the urine pH and Eh to shift away from normal whereas favorable effects cause them to shift toward normal.

Acid-Base Equilibrium↗
PubMed1975

[Ferrous ion oxidation and uranium solubilization from a lowgrade ore by "Thiobacillus ferrooxidans" (author's transl)].

The microbiological oxidation of ferrous ion and the extraction of uranium from a low-grade ore has been studied using an adapted strain of Thiobacillus ferrooxidans. The effect of temperature, pH, volumetric oxygen transfer coefficient, K1a, and aeration number, Ia, on the activity of the microorganism has been determined. The activation energy for ferrous iron oxidation was calculated to be - 13.9 +/- 0.1 kcal/mole and inactivation (thermal death of bacteria) 53.3 +/- 0.2 kcal/mole. Temperature coefficient, Q10, was estimated to be 1.8. Uranium extraction varied between 80 and 100%.

Hydrogen-Ion Concentration↗
PubMed1978

Studies on the mechanism of the malate dehydrogenase reaction.

The stereospecificity of the chicken heart mitochondrial malate dehydrogenase as well as the ability of this enzyme to form various abortive complexes has been further investigated. The enzyme was found to be specific for the A-hydrogen of NADH. Complex formation of the enzyme with oxalacetate and oxidized coenzymes is pH-dependent and is promoted at alkaline pH values. The enol form of oxalacetate appears to be the species that participates in the formation of the complexes. The binding of L-malate, D-malate, or hydroxymalonate to the enzyme. NADH complex is also pH-dependent, and involves a group on the enzyme with a pK of 7.5. The binding of L-malate is promoted at alkaline pH values, whereas the binding of D-malate and hydroxymalonate is favored at acidic pH values. These results indicate that L-malate and enol-oxalacetate preferentially or exclusively bind to the nonprotonated form of the enzyme, whereas keto-oxalactate, hydroxymalonate, and D-malate only bind to the protonated form of the enzyme. Based on this conclusion, a detailed chemical mechanism for the malate dehydrogenase reaction has been postulated and a schematic illustration of the transition state of the enzyme is presented.

Animals↗
PubMedDate not supplied

Biotransformation of prochiral 2-phenyl-1,3-di(4-pyridyl)-2-propanol to a chiral N-oxide metabolite.

The prochiral compound, 2-phenyl-1,3-di(4-pyridyl)-2-propanol (PPP) labeled with 3H in the phenyl ring, was administered to rats, dogs, and a human subject. Paper chromatography of the urine indicated that a major metabolite common to all three species was excreted. This metabolite was isolated from the urine of chronically dosed dogs and was identified by mass, nuclear magnetic resonance (NMR), and infrared spectrometry as the N-oxide, 2-phenyl-1-(4-pyridyl)-3-(4-pyridyl-1-oxide)-2-propanol. In addition, polarimetry indicated that this metabolite was levorotatory. Examination of the enantiomeric purity of a crystallized sample of the metabolite by NMR spectroscopy of resolvable diastereomeric salts formed with lasalocid revealed the presence of only the levorotatory enantiomer. Accordingly, this metabolic N-oxide formation in the dog was at least stereoselective, and perhaps stereospecific. The N-oxidation of PPP was also demonstrated in vitro with 9000 g supernatant fraction of rat liver fortified with an NADPH generating system, and this reaction was inducible by phenobarbital, indicating that it is mediated by the cytochrome P-450 mixed-function oxidase system. This study, in addition to providing another example of the pyridyl N-oxidation pathway, illustrates the necessity of considering the stereochemical aspects of the metabolism of prochiral drugs.

1-Propanol↗
PubMedDate not supplied

On the product of the reaction between cysteamine and 3-bromopyruvate.

Some properties of TZCA, the addition compounds of cysteamine and 3-bromopyruvate, have been investigated. From the behaviour of the UV absorption spectra in acidic and alkaline solutions in the presence or absence of oxygen, it was shown that the instability of TZCA was imputable to an oxidative degradation. It was further shown that TZCA undergoes in alkali spontaneous oxidative decarboxylation, and that the arising product may be hydrolyzed to cystamine and glyoxylic acid. Some chemical reactions and the paper chromatographic behaviour of TZCA are reported. It was shown that TZCA, despite its great instability, may be the reactions described, and thus differentiated from other adducts of bromopyruvate and different aminothiols.

Chemical Phenomena↗
PubMed1979

Mixed function oxidases in sterol metabolism. Separate routes for electron transfer from NADH and NADPH.

Oxidative deformylation of 4-hydroxy[14C]methylene-5alpha-cholest-7-en-3-one and oxidative demethylation of [30,31-14C]4,4-dimethyl-5alpha-cholest-7-en-3beta-ol by rat liver microsomes have been compared with regard to the manner in which electrons are introduced from both NADH and NADPH. Evidence suggests that NADH and NADPH support oxidation of both substrates via separate routes of electron transfer. Thus, 10 micron cytochrome c will inhibit NADPH-supported oxidation to 40 to 50% of control activity leaving NADH-supported oxidation unaffected. Also, treatment of microsomes with subtilisin diminishes NADPH-supported oxidation to 10 to 30% of control activity for either substrate to 70 to 90% of control activity while NADH-supported oxidative activity is virtually unaffected. Studies on the oxidase activities and NADPH-cytochrome c reductase as well as NADH-ferricyanide reductase have shown marked differences in activity in the presence of inhibitors. Thus, 9 mM 2'-AMP inhibits NADPH-cytochrome c reductase to 10 to 20% of control activity while NADPH-supported oxidative demethyl ation and deformylation are essentially unchanged. Mersalyl at 15 to 25 nmol/mg of microsomal protein inhibits both reductases to 20 to 40% of control activity; oxidative demethylation is unaffected and oxidative deformylation stimulated slightly when NADPH is used. Finally, antibody to NADPH-cytochrome c reductase inhibits oxidase activity for either substrate to 70 to 90% of control activity while reductase activity is inhibited to 10 to 30% of control activity.

Animals↗